ProfileGDS4718 / 207453_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 24% 37% 68% 27% 31% 23% 26% 30% 38% 30% 28% 31% 32% 24% 30% 26% 23% 28% 31% 36% 33% 28% 31% 28% 31% 28% 26% 27% 21% 30% 28% 49% 30% 25% 32% 27% 32% 32% 30% 76% 32% 29% 36% 27% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2941824
GSM549102patient 115, normal, homogenized [OPG study]4.867537
GSM549104patient 119, normal, homogenized [OPG study]6.7319768
GSM549108patient 138, normal, homogenized [OPG study]4.4520227
GSM549119patient 077, normal, homogenized [OPG study]4.6042331
GSM549133patient 032, cancer, homogenized [OPG study]4.2231723
GSM549139patient 042, cancer, homogenized [OPG study]4.359426
GSM549099patient 107, normal, homogenized [OPG study]4.545930
GSM549109patient 139, normal, homogenized [OPG study]4.9373538
GSM549110patient 046, normal, homogenized [OPG study]4.552730
GSM549114patient 063, normal, homogenized [OPG study]4.4252828
GSM549122patient 082, normal, homogenized [OPG study]4.5762131
GSM549134patient 033, cancer, homogenized [OPG study]4.5990332
GSM549136patient 036, cancer, homogenized [OPG study]4.2486924
GSM549140patient 044, cancer, homogenized [OPG study]4.4928230
GSM549111patient 047, normal, homogenized [OPG study]4.3562926
GSM549113patient 057, normal, homogenized [OPG study]4.1877223
GSM549132patient 031, cancer, homogenized [OPG study]4.4630328
GSM549137patient 038, cancer, homogenized [OPG study]4.5517731
GSM549142patient 047, cancer, homogenized [OPG study]4.9306736
GSM549100patient 110, normal, homogenized [OPG study]4.6760133
GSM549107patient 135, normal, homogenized [OPG study]4.4426128
GSM549115patient 068, normal, homogenized [OPG study]4.5243931
GSM549116patient 072, normal, homogenized [OPG study]4.4340228
GSM549120patient 078, normal, homogenized [OPG study]4.5938931
GSM549131patient 030, cancer, homogenized [OPG study]4.4084428
GSM549118patient 074, normal, homogenized [OPG study]4.3604826
GSM549129patient 027, cancer, homogenized [OPG study]4.4179927
GSM549123patient 088, normal, homogenized [OPG study]4.1772821
GSM549124patient 006, cancer, homogenized [OPG study]4.5618830
GSM549126patient 015, cancer, homogenized [OPG study]4.4409628
GSM549128patient 025, cancer, homogenized [OPG study]5.4751149
GSM549103patient 117, normal, homogenized [OPG study]4.595630
GSM549117patient 073, normal, homogenized [OPG study]4.3052925
GSM549138patient 041, cancer, homogenized [OPG study]4.5852232
GSM549141patient 045, cancer, homogenized [OPG study]4.3662727
GSM549130patient 028, cancer, homogenized [OPG study]4.6631532
GSM549101patient 111, normal, homogenized [OPG study]4.6330332
GSM549105patient 128, normal, homogenized [OPG study]4.555430
GSM549106patient 134, normal, homogenized [OPG study]7.563876
GSM549112patient 048, normal, homogenized [OPG study]4.6104132
GSM549125patient 011, cancer, homogenized [OPG study]4.4924129
GSM549127patient 024, cancer, homogenized [OPG study]4.7977636
GSM549135patient 035, cancer, homogenized [OPG study]4.3495527